Dermatomyositis
What's New
Last Posted: Oct 14, 2023
- Causal association between common rheumatic diseases and glaucoma: a Mendelian randomization study.
Yang Meng, et al. Frontiers in immunology 2023 0 1227138 - Leveraging Genomic and Bioinformatic Analysis to Enhance Drug Repositioning for Dermatomyositis.
Lalu Muhammad Irham, et al. Bioengineering (Basel, Switzerland) 2023 0 (8) - Association between HLA alleles and autoantibodies in dermatomyositis defined by sarcoplasmic expression of myxovirus resistance protein A.
Munenori Oyama, et al. The Journal of rheumatology 2023 0 - Diseases of the musculoskeletal system and connective tissue and risk of breast cancer: Mendelian randomization study in European and East Asian populations.
Yue-Chen Xu, et al. Frontiers in oncology 2023 0 1170119 - Anti-Sp4 autoantibodies co-occur with anti-TIF1 and are associated with distinct clinical features and immunogenetic risk factors in juvenile myositis.
Sherman Matthew A, et al. Arthritis & rheumatology (Hoboken, N.J.) 2023 0 - Analysis of anti-melanoma differentiation-associated gene 5 antibody in Hong Kong Chinese patients with idiopathic inflammatory myopathies: diagnostic utility and clinical correlations.
So Ho, et al. International journal of rheumatic diseases 2018 0 (5) 1076-1081 - Meta-Analysis of Polymyositis and Dermatomyositis Microarray Data Reveals Novel Genetic Biomarkers.
Song Jaeseung, et al. Genes 2019 0 (11) - Human leukocyte antigen in Japanese patients with idiopathic inflammatory myopathy.
Furukawa Hiroshi, et al. Modern rheumatology 2019 0 (4) 696-702 - Mortality in Patients with Polymyositis and Dermatomyositis in an Israeli Population.
Kridin Khalaf, et al. The Israel Medical Association journal : IMAJ 2020 0 (10) 623-627 - Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease.
Nishina Naoshi, et al. RMD open 2020 0 (2) - SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-?, and Point Mutation in the Transcription Intermediary Factor 1-? Coding Gene: A Case Report.
Arnon Johnathan, et al. JTO clinical and research reports 2021 0 (9) 100217 - Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis.
Sabbagh Sara E, et al. Clinical rheumatology 2021 0 (10) 4095-4100 - CD3Z polymorphisms and promoter hypermethylation in dermatomyositis - the role of cytosine-phosphate-guanine-related single nucleotide polymorphisms.
Saraeva Radoslava, et al. Immunological investigations 2021 0 (4) 817-825 - Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO Registry.
Zhang Lixi, et al. Clinical rheumatology 2021 0 (11) 4597-4608 - TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1? positive cancer-associated dermatomyositis.
Cordel Nadège, et al. Rheumatology (Oxford, England) 2021 0 (12) 5863-5867 - 47XXY and 47XXX in Scleroderma and Myositis.
Scofield R Hal, et al. ACR open rheumatology 2022 0 (6) 528-533 - The SNPs of mitochondrial DNA displacement loop region and mitochondrial DNA copy number associated with risk of polymyositis and dermatomyositis.
Zhao Yufei, et al. Scientific reports 2022 0 (1) 5903 - Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis.
Silva Marilda G, et al. Clinical and experimental rheumatology 2019 0 (4) 656-662 - Association with HLA-DR?1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis.
Deakin Claire T, et al. Human molecular genetics 2022 0 (14) 2471-2481 - Dermoscopy and Trichoscopy in Dermatomyositis-A Cross-Sectional Study.
?ychowska Magdalena, et al. Journal of clinical medicine 2022 0 (2)
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 21, 2024
- Content source: